The First Pavlov State Medical University of St. Petersburg is a higher education institution, medical university in St. Petersburg. PSPbGMU is called the First Medical Institute in St. Petersburg because of its renaming in 1936, relative to Saint Petersburg State Medical Academy named after I.I.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
St. Petersburg State Pavlov Medical University
4
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
3
Pfizer
2
National Research Center for Hematology, Russia
1
Clinical Trials at RM Gorbacheva Research Institute
During the past decade, RM Gorbacheva Research Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)
2021-01-21
2024-12-31
Recruiting
40
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "RM Gorbacheva Research Institute"
#1 collaborator was "Enrollme.ru, LLC" with 1 trials as a collaborator, "Foundation for Cancer Research Support (RakFond)" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at RM Gorbacheva Research Institute
According to Clinical.Site data, the most researched conditions in "RM Gorbacheva Research Institute" are
"Myelodysplastic Syndromes" (2 trials), "Myeloid Leukemia, Acute" (2 trials), "Myeloproliferative Neoplasm" (2 trials), "Acute Lymphoid Leukemia" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "RM Gorbacheva Research Institute" in a lesser frequency.
Clinical Trials Intervention Types at RM Gorbacheva Research Institute
Most popular intervention types in "RM Gorbacheva Research Institute" are "Drug" (7 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bendamustine Hydrochloride" (2 trials), "Mycophenolate Mofetil" (2 trials), "Brentuximab Vedotin" (1 trials), "Busulfan" (1 trials) and "Cranial irradiation" (1 trials). Other intervention names were less common.
Clinical Trials Genders at RM Gorbacheva Research Institute
The vast majority of trials in "RM Gorbacheva Research Institute" are
10 trials for "All" genders.
Clinical Trials Status at RM Gorbacheva Research Institute
Currently, there are NaN active trials in "RM Gorbacheva Research Institute".
1 are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in RM Gorbacheva Research Institute,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in RM Gorbacheva Research Institute, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".